Table of Contents
Chapter One: Executive Summary
- Scope and Methodology
- Markets - Pharmacists Impact
- The Prescribing Pharmacist
- Main Drivers For Increased Pharmacist Prescription Authority
- Issues and Trends Shaping the Industry
- Methodology
Chapter Two: Introduction
- History and Description
- Role of the US Pharmacist
- Role in Distributing Controlled Substances
- Variations in Prescribing Authority
- Pharmacists Statistics
- Overview
- Earnings and Distribution by Employment Type
- State Concentrations
- Training and Certification
Chapter Three: Issues and Trends Shaping the Industry
- US Healthcare Expenditures
- Rising Healthcare Costs and Health Insurance Trends
- Pharmaceutical Trends
- Units Sales and Revenues of Top Branded Drugs
- Population Growth and the Existing Need
- Medication Safety
- Medication Errors
- Reducing Errors in Hospitals
- Drug Interactions
- Interactions and the Evolving Pharmaceutical Industry
- Prescribing Trends of Select Federal Programs
- State Comparison of Collaborative Practice
- Hospital Case Studies and Collaborative Drug Therapy Management
- HCA Hospitals
- Barriers to Collaborative Practice
- International Trends
- England
- Scotland
- Wales
- Northern Ireland
- Canada
- Japan
- Australia
Chapter Four: Pharmacist Impact on Pharmaceutical Markets
- Overview
- The Pharmacist Influence
- Influencing Drug Choice
- Influencing Drug Dosage, Administration, or Other Therapy Aspects
- Therapeutic Areas Most Influenced
- chapter Five: The Emerging Prescribing Pharmacist
- Differing Views on Increasing Roles of the Pharmacist
- Physicians' View on Increasing Involvement in Prescribing
- Pharmacists' View on Increasing Involvement in Prescribing
- States Most Likely to Implement Independent Prescribing
- Market Impact
APPENDIX: Nationwide Boards of Pharmacy
table of exhibits
Chapter One: Executive Summary
- Figure 1-1: Declining Drug Purchases Not Influenced By Pharmacist 2006-2012
- Table 1-1: Pharmacists Influence in Drug Selection and/or Therapy Aspect:
2006 and 2012
- Figure 1-2: Pharmacists Influence in Drug Selection and/or Drug Aspect,
2006 and 2012
Chapter Two: Introduction
- Table 2-1: Examples of Controlled Substances by Schedule
- Table 2-2: Number of Pharmacists in the Workforce 2004-2006
- Table 2-3: 2004 Median Annual Income Levels for U.S. Pharmacists
- Figure 2-1: 2004 Median Annual Income Levels for U.S. Pharmacists
- Table 2-4: 2005 Leading Employment Areas and Income Statistics for U.S.
Pharmacists
- Table 2-5: 2006 Leading Employment Areas and Income Statistics for U.S.
Pharmacists
- Figure 2-2: Number of Pharmacists (2005/2006) in Leading Employment Areas
in the U.S.
- Figure 2-3: Mean Level of Income (2005/2006) for Leading Employment Areas
in the U.S.
- Table 2-6: Pharmacist Concentrations for the Top Five States in 2006
- Figure 2-4: Pharmacist Concentrations for the Top Five States in 2006
- Table 2-7: Pharmacist Concentrations for the Top Five U.S. Metropolitan
Areas in 2006
- Figure 2-5: Pharmacist Concentrations for the Top Five U.S. Metropolitan
Areas in 2006
- Table 2-8: Number of Pharmacists Employed in all U.S. States, District of
Columbia and U.S. Territories in 2006
- Figure 2-6: Top 20 States with the Most Pharmacists in the Workforce in
2006 Table 2-9: Accredited Pharmacy Education Centers by State
Chapter Three: Issues and Trends Shaping the Industry
- Table 3-1: U.S. Prescription and Total Healthcare Expenditures 1995, 2000,
and 2005
- Figure 3-1: U.S. Prescription and Total Healthcare Expenditures 1995,
2000, and 2005
- Table 3-2: Percent Insured in the U.S. by Income Level
- Figure 3-2: Percent Insured in the U.S. by Income Level
- Table 3-3: Health Insurance Trends in the United States 2003-2005
- Figure 3-3: Number Insured in the United States 2003-2005
- Table 3-4: Retail Pharmaceutical Sales in the U.S. 1995, 2000 and 2004
- Figure 3-4: Distribution of Retail Pharmaceutical Sales from 1995, 2000
and 2004
- Table 3-5: Top Ten Prescribed Branded Drugs by Estimated Unit Sales in the
U.S.
- Table 3-5: Top Ten Prescribed Branded Drugs by Estimated Unit Sales in the
U.S.
- Table 3-6: Top Ten Prescribed Branded Drugs and U.S. Revenues
- Figure 3-6: Top Ten Prescribed Branded Drugs and U.S. Revenues
- Table 3-7: Top Ten Prescribed Branded Drugs and Worldwide Revenues
- Figure 3-7: Top Ten Prescribed Branded Drugs and Worldwide Revenues
- Table 3-8: United States Population and Age Statistics
- Figure 3-8: United States Population and Age Statistics
- Table 3-9: Increase in the Oldest U.S. Population
- Figure 3-9: Increase in the Oldest U.S. Population
- Figure 3-10: Distribution of Fatal Prescribing Errors
- Table 3-10: Select 2007 Safety Alerts for Drugs and Therapeutic Biological
Products
- Table 3-11: Drug Interaction Information
- Figure 3-11: Timeline of U.S. Pharmacy Collaboration
- Table 3-12: States That Allow Collaboration Agreements between Pharmacist
and Physician
- Table 3-13: Pharmacists per Employment Category in Japan (2004)
Chapter Four: Pharmacist Impact on Pharmaceutical Markets
- Table 4-1: Pharmacists Influence in Drug Selection and/or Drug Therapy
Aspect, 2006 and 2012
- Figure 4-1 : Pharmacists Influence in Drug Selection and/or Therapy
Aspect, 2006 and 2012
- Table 4-2: Pharmacists Influence in the US Drug Market, Influencing Drug
Choice, 2006
- Figure 4-2: Pharmacists Influence in the US Drug Market, Influencing Drug
Choice, 2006
- Figure 4-3: Drug Markets Most Influenced by Pharmacists by Therapeutic
Category, 2006
- Table 4-3: Pharmacists Influence in the US Drug Market, Influencing Drug
Dosage, Administration, and Other Therapy Aspect, 2006
- Figure 4-3: Pharmacists Influence in the US Drug Market, Influencing Drug
Dosage, Administration, and Other Therapy Aspect, 2006
Chapter Five: The Emerging Prescribing Pharmacist
- Table 5-1: States Most Likely to Allow Prescription, Those to Follow, and
States Not Likely to Allow Independent Prescribing
|
Related Report
|
View Cart
